Balance Sheet for Edwards Lifesciences Corporation (EW)

$ 83.88   -0.01 (-0.01%) Volume: 2.53m 4:00 PM EST Dec 1, 2020
After Hours:  $ 84.50   0.62 (+0.74%) Volume: 271.09k 5:41 PM EST Dec 1, 2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 1,179 714 818 930 718
Restrictable Cash - - - - -
Marketable Securities 338 242 519 341 506
Accounts Receivable 544 457 439 366 315
Loans Receivable - - - - -
Other Receivables 56 80 41 49 56
Receivables 599 537 479 415 372
Inventories, Raw Materials 118 112 101 61 64
Inventories, Work in Progress 122 145 121 102 64
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 401 351 332 234 212
Inventories, Other 641 607 555 397 340
Inventories, Adjustments & Allowances - - - - -
Inventories 641 607 555 397 340
Prepaid Expenses 59 54 61 46 45
Current Deferred Income Taxes - - - - 201
Other Current Assets 168 132 117 112 66
Total Current Assets 2,984 2,287 2,549 2,240 2,048
Land and Improvements 98 91 39 30 25
Buildings and Improvement 620 497 437 367 293
Machinery, Furniture and Equipment 590 566 528 484 461
Construction in Progress 265 169 88 80 75
Fixed Assets, Other 80 - - - -
Fixed Assets, Total 1,653 1,323 1,092 961 854
Gross Fixed Assets 1,653 1,323 1,092 961 854
Accumulated Depreciation (512) (455) (412) (381) (372)
Net Fixed Assets 1,140 868 680 580 482
Intangibles 336 343 468 205 205
Cost in Excess 1,168 1,112 1,126 626 628
Non-Current Deferred Income Taxes 172 174 167 204 180
Other Non-Current Assets 102 34 109 123 132
Total Non-Current Assets 3,504 3,037 3,117 2,270 2,008
Total Assets 6,488 5,324 5,666 4,510 4,056
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 180 134 117 97 64
Short Term Debt 26 1,798 598 - -
Notes Payable - - - - -
Accrued Expenses 270 245 225 160 144
Accrued Liabilities 270 245 225 160 144
Deferred Revenues - - - - -
Current Deferred Income Taxes 12 (27) 18 (37) (95)
Other Current Liabilities 426 (1,300) 481 275 237
Total Current Liabilities 902 877 1,420 532 476
Long Term Debt 594 594 438 822 597
Deferred Income Tax - - - - -
Other Non-Current Liabilities 784 713 852 536 480
Minority Interest - - - - -
Capital Lease Obligations 59 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 1,437 1,307 1,290 1,358 1,077
Total Liabilities 2,340 2,183 2,710 1,891 1,553
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 4,148 3,140 2,956 2,619 2,503
Common Par 218 215 212 243 239
Additional Paid in Capital 1,623 1,384 1,167 1,168 947
Cumulative Translation Adjustments - - - - -
Retained Earnings 3,742 2,695 1,962 3,906 3,337
Treasury Stock 1,279 1,015 252 2,499 1,837
Other Equity Adjustments (156) (138) (133) (198) (183)
Total Capitalization 4,743 3,734 3,395 3,441 3,100
Total Equity 4,148 3,140 2,956 2,619 2,503
Total Liabilities & Shareholder's Equity 6,488 5,324 5,666 4,510 4,056
Cash Flow 1,047 722 584 570 495
Working Capital 2,082 1,410 1,129 1,708 1,572
Free Cash Flow 901 685 825 487 443
Invested Capital 4,743 3,734 3,395 3,441 3,100
Shares Outstanding - Common Class Only 627 623 629 212 215
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 627 623 629 212 215
Total Common Shares Outstanding 627 623 629 212 215
Treasury Shares 27 22 7 31 24
Basic Weighted Shares Outstanding 625 628 633 213 216
Diluted Weighted Shares Outstanding 637 641 648 218 220